National Cardiogenic Shock Initiative (CSI) Protocol
Sites participating in the National Cardiogenic Shock Initiative (CSI) have adopted the National CSI algorithm as the foundatio...
The Benefit and Efficacy of Complete Revascularization in a Single Setting
Read more about comprehensive and well-documented data that demonstrates how complete revascularization has distinct clinical a...
Evolving Evidence for Protected PCI with Impella to Treat High-Risk Complex CAD Patients
Results from the PROTECT clinical studies consistently demonstrate a reduction in MACCE at 90 days after Protected PCI with the...
Current PCI Landscape and Opportunities for Improvement
An overview of the landscape, contemporary data, quality measures, and technological trends that will guide complex CAD cases t...
Single-Access with 14 F Impella Sheath Procedural Steps
Abiomed’s Impella CP Introducer* was recently FDA cleared1 , and is being released to users. It has a 14 French (F)...
High-Risk PCI Involving Chronic Kidney Disease, PVD and LV-dysfunction
Dr. Flaherty presents a case review of an 85-year-old male who presented with unstable angina symptoms, multivessel coronary ar...
Impella Protects Against AKI in HRPCI
With Impella support in high-risk PCI, overall incidence of post-procedural AKI is significantly re...
WellStar Hub and Spoke Cardiogenic Shock Treatment Network
Successful Implementation of Cardiogenic Shock Algorithm Dr. Salvatore Mannino discusses the...
Largest FDA Study of High-Risk PCI Patients Shows Improved Outcomes with Impella® Heart Pumps
Jeffrey J. Popma, MD, presents the latest data from the PROTECT series clinical study...
Allegheny Health Network Protected PCI Algorithm
Download the Allegheny Health Network Protected PCI Algorithm to guide decision-making for appropriate use of the Impella® hear...
New Data from NCSI Demonstrates 72% Survival with 98% Native Heart Recovery
New data from the National Cardiogenic Shock Initiative Study (NCSI) on 171 consecutive AMI cardiogenic shock (AMICS) patients...
Hub-Spoke Patient Transfer Packet
Use this patient transfer checklist and documentation when transferring a patient supported with an Impella® device from the "...
For Best Outcomes in AMI Cardiogenic Shock, Place Impella 2.5® or Impella CP® Pre-PCI
A preponderance of evidence from the FDA cVAD Study, Impella Quality Assurance Database and physician-initiated National Cardio...
Impella Updates – Reaccess Sheath
This sheath enables reaccess to the artery for the duration of Impella support with up to an 0.035” guidewire. The additional s...
Dr. O’Neill’s IQ Data and AMICS Presentation from TCT 2018
Adoption of best practices improves survival for patients with Acute Myocardial Infarction and Cardiogenic Shock (AMICS) suppor...
Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device
Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) data...
Step-by-Step Guide to Right Heart Unloading with Impella RP®
The Impella RP is the only FDA approved support device for the treatment of right heart failure....
Mt. Sinai Protected PCI Algorithm
Download the Mt. Sinai Protected PCI Algorithm to guide decision-making for appropriate use of the Impella 2.5 and Impella CP h...
WVU Heart & Vascular Institute’s high-risk PCI algorithm
Download the WVU Heart & Vascular Institute Complete Revascularization of Complex and High Risk Coronary Artery Disease Alg...
Complex PCI with Multiple Comorbidities
Dr. Tanveer Rab of Emory University joins Dr. Cathy Jeon to discuss a case of an 80 year old male with a low ejection fraction...
Henry Ford Algorithm
This is a sample high-risk PCI algorithm used by Henry Ford Health System. Specifically, it is a Left Ventricular Mechanical Ci...
INOVA Heart and Vascular Institute Protected PCI Algorithm
Download INOVA Heart and Vascular Institute’s Protected PCI algorithm, which begins with a heart team evaluation of high risk c...
Cardiogenic Shock Clinical Dossier
Impella 2.5®, Impella CP®, Impella 5.0®, and Impella LD® heart pumps are now FDA i...
Estimating Impella 5.0/LD Flow from Motor Current
Abiomed has observed that when clinicians encounter an unreliable differential pressure sensor while a patient is being support...
